Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians

Canada News News

Pneumococcal Vaccine Uptake Remains Low in At-Risk Canadians
Canada Latest News,Canada Headlines
  • 📰 Medscape
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 55%

Pneumococcal vaccination uptake remains low among high-risk adults in Canada, including those aged 65 years or older and patients with chronic conditions, according to a new report.

In Canada, pneumococcal vaccination is recommended for patients aged 65 years and older, as well as for adults younger than 65 years who have one or more chronic medical conditions. The Canadian National Immunization Strategy set an 80% coverage target to be achieved by 2025, though current uptake falls short of that goal.

About 76% of patients aged 65 years and older reported being diagnosed with at least one chronic medical condition. About 57.1% of this group reported receiving a pneumococcal vaccine, compared with 43.8% of participants who did not have an underlying condition. In addition, among those who had had contact with a family doctor in the past year, 44.8% of patients aged 65 years and older and 80.4% of patients aged 47 to 64 years with a chronic condition didn't get vaccinated.

"I think it's important to underline that, with COVID-19 still circulating and resurging and the flu season starting, this is the right time to get vaccinated against pneumococcal disease as well," Sulis said."Pneumococcus often causes secondary infections in people who have been infected with a respiratory virus, such as the flu, increasing the risk of hospitalization and death.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Medscape /  🏆 386. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca Drops Plan to Sell Covid-19 Vaccine in U.S.AstraZeneca Drops Plan to Sell Covid-19 Vaccine in U.S.AstraZeneca said it had dropped plans to submit its Covid-19 vaccine to the Food and Drug Administration for approval
Read more »

Samuel L. Katz, a developer of the measles vaccine, dies at 95Samuel L. Katz, a developer of the measles vaccine, dies at 95Dr. Samuel L. Katz, a virologist who was part of the research team at Harvard Medical School that developed the measles vaccine, an advance more than half a century ago that has saved countless lives, died Oct. 31 at his home in Chapel Hill, North Carolina. He was 95.
Read more »

U.S. Supreme Court's Sotomayor rejects challenge to N.Y. COVID vaccine mandateU.S. Supreme Court's Sotomayor rejects challenge to N.Y. COVID vaccine mandate(Reuters) -U.S. Supreme Court Justice Sonia Sotomayor on Thursday rejected a bid to prevent New York City from enforcing its COVID-19 vaccine mandate for municipal workers against a group teachers, firefighters and others who challenged the policy. The justice denied an emergency request, received by the court on Nov. 4, to block the policy by individual municipal workers, as well as a group called New Yorkers For Religious Liberty, while their appeal of lower court decisions siding with the city proceeds. The plaintiffs - firefighters, building inspectors, police officers, emergency medical technicians, teachers, sanitation workers and others - are represented by the Alliance Defending Freedom conservative religious liberty group.
Read more »

Justice Sonia Sotomayor declines to block NYC public sector Covid-19 vaccine mandate | CNN PoliticsJustice Sonia Sotomayor declines to block NYC public sector Covid-19 vaccine mandate | CNN PoliticsJustice Sonia Sotomayor on Thursday rejected a request that the Supreme Court block New York City's public sector Covid-19 vaccine requirement as it applies to employees with who have religious objections to the vaccine.
Read more »



Render Time: 2025-02-27 09:12:33